ÁÖ»ç¿ë »ý¹°Á¦Á¦ ½ÃÀå : ±â¼ú, Ä¡·á, ½ÃÀå, Àü·«, ¿¹Ãø
Injectable Biological Drugs - Technologies, Therapeutics, Markets, Strategies & Forecasts
»óǰÄÚµå : 1645733
¸®¼­Ä¡»ç : Greystone Research Associates
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 128 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,850 £Ü 5,440,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,771,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ÇÑ ºÎ¼­¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 3ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,500 £Ü 12,010,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 10ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾àÁ¦ Ŭ·¡½ºº°·Î º¸¸é »ý¹°Á¦Á¦´Â °³¹ß ÆÄÀÌÇÁ¶óÀΰú ÀÓ»ó½ÃÇè¿¡¼­ ´Ù¸¥ ¸ðµç ½Å±Ô È­Çй°ÁúÀ» °è¼Ó ´É°¡Çϰí ÀÖ½À´Ï´Ù. »ý¹°Á¦Á¦´Â ¸¸¼ºÁúȯÀ» ´ë»óÀ¸·Î ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ Åõ¿© Àü·«°ú Ä¡·á ÇÁ·ÎÅäÄÝÀº Àå±âÀûÀÎ »ç¿ëÀ» °ßµô ¼ö ÀÖµµ·Ï °³¹ßµÇ¾î¾ß Çϸç, Á¾Á¾ Áúȯ°ú Á÷Á¢ÀûÀ¸·Î °ü·ÃµÈ Á¦ÇÑÀ» ¹ÞÀ» ¼ö Àִ ȯÀÚ°¡ ½º½º·Î Åõ¿©ÇÒ ¼ö ÀÖµµ·Ï °³¹ßµÇ¾î¾ß ÇÕ´Ï´Ù. Ç×ü, È£¸£¸ó, È¿¼Ò ¹× ±âŸ »ý¹°ÇÐÀû ¾à¹°ÀÇ °­·ÂÇÑ »ý¸®Àû ÀÛ¿ëµµ ¾ÈÀü¼º°ú ¼øÀÀµµÀÇ Çʿ伺À» Áõ°¡½Ãŵ´Ï´Ù. ¾à¹° °³¹ß ÁÖ±âÀÇ Ãʱ⠴ܰèºÎÅÍ µð¹ÙÀ̽º ¼³°èÀÚ¿Í ÀǾàǰ °³¹ßÀÚ°¡ Çù·ÂÇÏ¿© ƯÁ¤ ¾à¹° ¿ä¹ýÀÇ »ýü ÀÌ¿ë·ü ¸ñÇ¥¿Í ¾àµ¿ÇÐÀû ÇÁ·ÎÆÄÀÏ¿¡ ¸Â°Ô µð¹ÙÀ̽º¸¦ ¼³°èÇÒ ¼ö ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÇöÀç °³¹ßÁßÀÎ »õ·Î¿î ÁÖ»çÁ¦ Àü´Þ Àåºñ ¼³°è´Â »õ·Î¿î ÁÖ»çÁ¦ ´ë¾È¿¡ ´ëÇÑ »õ·Î¿î ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±â±â °ø±Þ¾÷ü¿Í Á¦¾à»ç °£ÀÇ ÆÄÆ®³Ê½ÊÀº Ä¡·á¿ë ¹é½Å, DNA ±â¹Ý ¾à¹°, ´Ü¹éÁú À¯·¡ »ý¹°Á¦Á¦ µî ¸¹Àº »õ·Î¿î Ä¡·á¹ýÀ» À§ÇÑ »õ·Î¿î ÁÖ»çÁ¦ ±â±â ½ÃÀå ¼ö¿ëÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸®Æ÷Æ® °¡Ä¡ ¸ÅÆ®¸¯½º

ÁÖ»ç¿ë »ý¹°Á¦Á¦ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ȯÀÚ ¹ÌÃæÁ· ¿ä±¸ µîÀÇ ½ÃÀåÀÇ ±âȸ, »ý¹°Á¦Á¦ ¾à¹°Àü´ÞÀÇ °úÁ¦¿Í ÇѰè, ¾àÁ¦ Ŭ·¡½ºº° Á¦Ç° ºÐ¼® ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

°³¿ä

½ÃÀå ±âȸ

»ý¹°Á¦Á¦ ¾à¹°Àü´Þ - °úÁ¦¿Í ÇѰè

ÀǾàǰ Àü·«°ú Ä¡·á¿ë ´Ü¹éÁú Æ÷Àå

ÁÖ»ç¿ë »ý¹°Á¦Á¦ - ¾àÁ¦ Ŭ·¡½ºº° Á¦Ç° ºÐ¼®

Ä¡·á ½ÃÀå ºÎ¹® ºÐ¼®

½ÃÀå ¿äÀÎ

±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

"Injectable Biological Drugs: Technologies, Therapeutics, Markets, Strategies and Forecasts" is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for injection devices for administering biologicals. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

New Platforms for Biological Drug Delivery

Biological drugs as a class continue to outpace all other NCEs in development pipelines and clinical trials. Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition. The powerful physiological effects of antibodies, hormones, enzymes and other biological drugs also increase the need for safety and adherence. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies. New injectable delivery device designs currently being developed will create new opportunities for alternative injection methods. Partnerships between device suppliers and pharmaceutical companies will foster market acceptance of new injection devices for a host of new therapies such as therapeutic vaccines, DNA-based drugs, and protein-derived biologics.

Report Value Matrix

What You Will Learn:

Table of Contents

Executive Summary

The Market Opportunity

Biological Drug Delivery - Challenges and Limitations

Drug Strategies & Therapeutic Protein Packaging

Injectable Biologicals - Product Analysis by Drug Class

Therapeutic Market Segment Analysis

Market Factors

Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â